The role of Moz, an epigenetic regulator, in the pathogenesis of leukaemia [ 2012 - 2014 ]

Also known as: The Role of Moz in Cancer

Research Grant

[Cite as]

Researchers: A/Pr Tim Thomas (Principal investigator) ,  A/Pr Anne Voss Prof Jonathan Baell

Brief description We are studying the oncogene and epigenetic regulator MOZ, (monocytic leukaemia zinc finger protein), with the aim firstly of better understanding the pathogenesis of cancer and secondly developing a new class of anti-cancer drugs.

Funding Amount $AUD 713,872.78

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]